- Home
- VNRX vs NVNI Comparison
VNRX vs NVNI Comparison
Compare VNRX & NVNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- NVNI
- Stock Information
- Founded
- VNRX N/A
- NVNI 2019
- Country
- VNRX United States
- NVNI Brazil
- Employees
- VNRX N/A
- NVNI N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NVNI
- Sector
- VNRX Health Care
- NVNI
- Exchange
- VNRX Nasdaq
- NVNI Nasdaq
- Market Cap
- VNRX 69.7M
- NVNI 57.2M
- IPO Year
- VNRX N/A
- NVNI N/A
- Fundamental
- Price
- VNRX $0.39
- NVNI $3.23
- Analyst Decision
- VNRX Strong Buy
- NVNI
- Analyst Count
- VNRX 4
- NVNI 0
- Target Price
- VNRX $3.50
- NVNI N/A
- AVG Volume (30 Days)
- VNRX 1.1M
- NVNI 275.5K
- Earning Date
- VNRX 11-14-2025
- NVNI 09-30-2025
- Dividend Yield
- VNRX N/A
- NVNI N/A
- EPS Growth
- VNRX N/A
- NVNI N/A
- EPS
- VNRX N/A
- NVNI N/A
- Revenue
- VNRX $1,319,252.00
- NVNI $31,250,627.00
- Revenue This Year
- VNRX $324.32
- NVNI $12.05
- Revenue Next Year
- VNRX $247.82
- NVNI $15.02
- P/E Ratio
- VNRX N/A
- NVNI N/A
- Revenue Growth
- VNRX 35.10
- NVNI 1491.58
- 52 Week Low
- VNRX $0.39
- NVNI $1.44
- 52 Week High
- VNRX $0.94
- NVNI $121.90
- Technical
- Relative Strength Index (RSI)
- VNRX 29.55
- NVNI 51.43
- Support Level
- VNRX $0.42
- NVNI $3.17
- Resistance Level
- VNRX $0.48
- NVNI $3.47
- Average True Range (ATR)
- VNRX 0.04
- NVNI 0.32
- MACD
- VNRX 0.00
- NVNI -0.17
- Stochastic Oscillator
- VNRX 2.22
- NVNI 13.76
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.